Oxford MEStar will collaborate with UCL and Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics.
Successful delivery of this program will lead to the development of a novel scaffold that can be used clinically in a one-step surgical procedure for treatment of large osteochondral defects. As a result, the quality of life of individuals with these defects, which often lead to osteoarthritis, will be improved allowing a pain free, more active lifestyle.
With the core technical expertise in bioprocessing, bioengineering and bio-manufacture and extensive network of investors, Oxford MEStar will bring the collaboration with UCL and Collagen Solutions to new heights. ”
Link to Collagen Solutions: http://www.collagensolutions.com/content/news/2015/140715.asp
About UCL (University College London)
UCL was founded in 1826. It is the first English university established after Oxford and Cambridge, the first to open up university education to those previously excluded from it, and the first to provide systematic teaching of law, architecture and medicine. We are among the world’s top universities, as reflected by performance in a range of international rankings and tables. UCL currently has over 35,000 students from 150 countries and over 11,000 staff. www.ucl.ac.uk | Follow us on Twitter @uclnews | Watch our YouTube channel YouTube.com/UCLTV
